WallStreetZenWallStreetZen

NASDAQ: EPIX
Essa Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for EPIX

Based on 1 analyst offering 12 month price targets for Essa Pharma Inc.
Min Forecast
$17.00+172%
Avg Forecast
$17.00+172%
Max Forecast
$17.00+172%

Should I buy or sell EPIX stock?

Based on 1 analyst offering ratings for Essa Pharma Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EPIX stock forecasts and price targets.

EPIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-13

1 of 1

Forecast return on equity

Is EPIX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is EPIX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

EPIX revenue forecast

What is EPIX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$22.3M
Avg 2 year Forecast
$174.4M
Avg 3 year Forecast
$144.1M

EPIX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EPIX$6.25$17.00+172.00%Buy
RAPT$7.90$21.00+165.82%Buy
NBTX$5.90$11.00+86.44%Buy
GLUE$5.47$11.00+101.10%Buy
ENTA$12.92$20.75+60.60%Hold
View Top Biotech Stocks

Essa Pharma Stock Forecast FAQ

Is Essa Pharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: EPIX) stock is to Buy EPIX stock.

Out of 1 analyst, 0 (0%) are recommending EPIX as a Strong Buy, 1 (100%) are recommending EPIX as a Buy, 0 (0%) are recommending EPIX as a Hold, 0 (0%) are recommending EPIX as a Sell, and 0 (0%) are recommending EPIX as a Strong Sell.

If you're new to stock investing, here's how to buy Essa Pharma stock.

What is EPIX's revenue growth forecast for 2026-2028?

(NASDAQ: EPIX) Essa Pharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Essa Pharma's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast EPIX's revenue for 2026 to be $985,183,534, with the lowest EPIX revenue forecast at $985,183,534, and the highest EPIX revenue forecast at $985,183,534. On average, 1 Wall Street analysts forecast EPIX's revenue for 2027 to be $7,714,690,455, with the lowest EPIX revenue forecast at $7,714,690,455, and the highest EPIX revenue forecast at $7,714,690,455.

In 2028, EPIX is forecast to generate $6,373,080,171 in revenue, with the lowest revenue forecast at $1,293,965,800 and the highest revenue forecast at $15,034,776,639.

What is EPIX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: EPIX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is EPIX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EPIX price target, the average EPIX price target is $17.00, with the highest EPIX stock price forecast at $17.00 and the lowest EPIX stock price forecast at $17.00.

The Wall Street analyst predicted that Essa Pharma's share price could reach $17.00 by Dec 13, 2024. The average Essa Pharma stock price prediction forecasts a potential upside of 172% from the current EPIX share price of $6.25.

What is EPIX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: EPIX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.